Rothera Mark's Form 4 filing
Viracta Therapeutics, Inc. (VIRX) · filed Dec 4, 2023
- Accession no.
- 0001209191-23-057239
- Filed
- Dec 4, 2023, 4:54 PM ET
- Trade date
- Nov 30-Dec 1, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $49.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothera MarkCIK 0001550424 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | Common Stock | PPurchaseAcquired | +52,094 | $0.494 | +$25,734.44 | 52,094 | Direct | |
| Dec 1, 2023 | Common Stock | PPurchaseAcquired | +47,906 | $0.4932 | +$23,627.24 | 100,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.